Trial Profile
Randomized Double-Blind, Multi-Center Study Of Efficacy And Tolerability Of Pregabalin Versus Placebo As An Adjunct To Standard Of Care For Perioperative Management Of Patients Undergoing Primary or secondary Total Hip Arthroplasty - Not applicable
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 01 Feb 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 01 Jul 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 07 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Sep 2011 New source identified and integrated (Clinical Trials Registry - India).